you are here:

GlaxoSmithKline Pharmaceuticals Ltd.

BSE: 500660 | NSE: GLAXO |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE159A01016 | SECTOR: Pharmaceuticals

BSE Live

Apr 12, 16:00
1454.50 8.70 (0.60%)
Volume
AVERAGE VOLUME
5-Day
1,932
10-Day
2,497
30-Day
3,929
4,086
  • Prev. Close

    1445.80

  • Open Price

    1465.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

NSE Live

Apr 12, 15:57
1455.15 9.10 (0.63%)
Volume
AVERAGE VOLUME
5-Day
58,072
10-Day
45,263
30-Day
45,869
70,780
  • Prev. Close

    1446.05

  • Open Price

    1444.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    1455.15 (34)

Financials

2020 2019 2018 2017 2016
Profit & Loss account of GlaxoSmithKline Pharmaceuticals (in Rs. Cr.) Mar 20 Mar 19 Mar 18 Mar 17 Mar 16  
  12 mths 12 mths 12 mths 12 mths 12 mths  
INCOME  
Revenue From Operations [Gross] 3,187.35 3,089.48 2,820.03 2,920.79 2,753.02  
Less: Excise/Sevice Tax/Other Levies 0.00 0.00 24.19 91.52 91.03  
Revenue From Operations [Net] 3,187.35 3,089.48 2,795.84 2,829.27 2,662.00  
Total Operating Revenues 3,224.68 3,128.53 2,871.69 2,902.99 2,735.19  
Other Income 77.56 101.48 53.52 72.01 121.83  
Total Revenue 3,302.24 3,230.01 2,925.21 2,975.00 2,857.01  
EXPENSES  
Cost Of Materials Consumed 474.38 682.07 510.27 523.58 632.17  
Operating And Direct Expenses 0.00 0.00 0.00 0.00 0.00  
Changes In Inventories Of FG,WIP And Stock-In Trade -35.43 25.57 -57.94 79.49 -144.49  
Employee Benefit Expenses 628.55 537.20 523.40 483.01 443.37  
Finance Costs 6.34 0.55 0.19 0.25 0.00  
Depreciation And Amortisation Expenses 82.68 48.59 37.99 26.35 24.95  
Other Expenses 629.81 631.33 599.10 606.27 587.44  
Total Expenses 2,655.24 2,571.20 2,401.42 2,509.65 2,283.38  
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax 646.99 658.82 523.79 465.35 573.63  
Exceptional Items -324.49 4.89 17.80 45.73 2.31  
Profit/Loss Before Tax 322.50 663.71 541.58 511.08 575.94  
Tax Expenses-Continued Operations  
Current Tax 235.31 192.82 204.34 162.97 207.49  
Less: MAT Credit Entitlement 0.00 0.00 0.00 0.00 0.00  
Deferred Tax -47.72 45.52 -14.74 11.33 -6.08  
Tax For Earlier Years 24.86 0.00 0.00 0.00 0.00  
Total Tax Expenses 212.45 238.35 189.60 174.30 201.41  
Profit/Loss After Tax And Before ExtraOrdinary Items 110.05 425.36 351.99 336.78 374.53  
Profit/Loss From Continuing Operations 110.05 425.36 351.99 336.78 374.53  
Profit/Loss For The Period 110.05 425.36 351.99 336.78 374.53  
OTHER ADDITIONAL INFORMATION  
EARNINGS PER SHARE  
Basic EPS (Rs.) 6.50 25.11 41.56 39.76 44.22  
Diluted EPS (Rs.) 6.50 25.11 41.56 39.76 44.22  
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS  
Imported Raw Materials 0.00 0.00 0.00 0.00 69.17  
Indigenous Raw Materials 0.00 0.00 0.00 0.00 567.80  
STORES, SPARES AND LOOSE TOOLS  
Imported Stores And Spares 0.00 0.00 0.00 0.00 0.00  
Indigenous Stores And Spares 0.00 0.00 0.00 0.00 0.00  
DIVIDEND AND DIVIDEND PERCENTAGE  
Equity Share Dividend 338.81 296.46 254.11 423.52 529.39  
Tax On Dividend 69.64 60.94 51.73 86.22 107.77  
Equity Dividend Rate (%) 400.00 200.00 350.00 300.00 500.00  
Source : Dion Global Solutions Limited